BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11471364)

  • 1. [Interest in and limitations of economic assessment applied to the evaluation of medical strategies: examples in oncological hematology].
    Moatti JP
    Therapie; 2001; 56(2):135-8. PubMed ID: 11471364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Future-oriented hemato-oncology in times of confusion in health politics].
    Niederwieser D; Hiddemann W
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2385. PubMed ID: 17054052
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methodology of economic assessment: example in oncology].
    Jaisson-Hot I; Schott AM; Clippe C; Ganne C; Hajri T; Poncet B; Trillet-Lenoir V; Colin C
    Bull Cancer; 2003 Nov; 90(11):939-45. PubMed ID: 14706896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rationalization, rationing, prioritization: terminology and ethical approaches to the allocation of limited resources in hematology/oncology].
    Winkler E
    Onkologie; 2011; 34 Suppl 1():2-5. PubMed ID: 21389761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on bacteraemia in oncology and hematology.
    Fortún J; Sanz MÁ; Madero L; López J; de la Torre J; Jarque I; Vallejo C
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 4():48-53. PubMed ID: 21458720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on fungemia in oncology and hematology.
    Carreras E; Vázquez L; Rodríguez Tudela JL; Pahisa A; Azanza JR; Rovira M; de la Cámara R
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 4():42-7. PubMed ID: 21458719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Major therapeutic advances and new perspectives in onco-hematology].
    Bay JO; Guièze R; Ravinet A; Lemal R; Xhaard A; Bailly S; Moluçon-Chabrot C; Hermet E; Biau J; Verrelle P; Peffault de Latour R; Tournilhac O
    Bull Cancer; 2013 Jun; 100(6):587-99. PubMed ID: 23735575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benefit-risk evaluation of new drugs as a basis for decisions on prioritization in hematology/oncology: methodical challenges and problem-solving strategies].
    Ludwig WD; Schildmann J
    Onkologie; 2011; 34 Suppl 1():6-10. PubMed ID: 21389762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of self-adapting G-DRG system 2004 to 2006 on in-patient services payment in pediatric hematology and oncology patients of a university hospital].
    Christaras A; Schaper J; Strelow H; Laws HJ; Göbel U
    Klin Padiatr; 2006; 218(6):366-78. PubMed ID: 17080340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outpatient hospital technologies in hematology].
    Tsyba NN
    Ter Arkh; 2006; 78(7):62-7. PubMed ID: 16944753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of pediatric hematology/oncology as an independent specialty.
    Pochedly C
    Am J Pediatr Hematol Oncol; 1985; 7(2):183-90. PubMed ID: 3842562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic evaluation in oncology].
    Schöffski O
    Med Klin (Munich); 2000 Jun; 95 Suppl 1():14-7. PubMed ID: 10941248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficiency-based healthcare. General concepts on economic evaluation of healthcare interventions].
    Catalá-López F
    Enferm Clin; 2009; 19(1):35-42. PubMed ID: 19233020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economy and medicine in haematology and oncology].
    Krych M; Ostermann H
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2115-8. PubMed ID: 18985566
    [No Abstract]   [Full Text] [Related]  

  • 15. Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model.
    Dalley C; Basarir H; Wright JG; Fernando M; Pearson D; Ward SE; Thokula P; Krishnankutty A; Wilson G; Dalton A; Talley P; Barnett D; Hughes D; Porter NR; Reilly JT; Snowden JA
    J Clin Pathol; 2015 Apr; 68(4):292-300. PubMed ID: 25631214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpreting the economic literature in oncology.
    Grusenmeyer PA; Wong YN
    J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent advances in haematology and oncology].
    Jäger U; Hiddemann W
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2077. PubMed ID: 18985558
    [No Abstract]   [Full Text] [Related]  

  • 18. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer care, money, and the value of life: whose justice? Which rationality?
    Sulmasy DP
    J Clin Oncol; 2007 Jan; 25(2):217-22. PubMed ID: 17210943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Haematology and oncology: in the vanguard of modern medicine].
    Ho AD; Hiddemann W
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1921. PubMed ID: 19760550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.